Final Report of a Trial of Intensive versus Standard Blood-Pressure Control
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In a previously reported randomized trial of standard and intensive systolic blood-pressure control, data on some outcome events had yet to be adjudicated and post-trial follow-up data had not yet been collected. METHODS: We randomly assigned 9361 participants who were at increased risk for cardiovascular disease but did not have diabetes or previous stroke to adhere to an intensive treatment target (systolic blood pressure, <120 mm Hg) or a standard treatment target (systolic blood pressure, <140 mm Hg). The primary outcome was a composite of myocardial infarction, other acute coronary syndromes, stroke, acute decompensated heart failure, or death from cardiovascular causes. Additional primary outcome events occurring through the end of the intervention period (August 20, 2015) were adjudicated after data lock for the primary analysis. We also analyzed post-trial observational follow-up data through July 29, 2016. RESULTS: At a median of 3.33 years of follow-up, the rate of the primary outcome and all-cause mortality during the trial were significantly lower in the intensive-treatment group than in the standard-treatment group (rate of the primary outcome, 1.77% per year vs. 2.40% per year; hazard ratio, 0.73; 95% confidence interval [CI], 0.63 to 0.86; all-cause mortality, 1.06% per year vs. 1.41% per year; hazard ratio, 0.75; 95% CI, 0.61 to 0.92). Serious adverse events of hypotension, electrolyte abnormalities, acute kidney injury or failure, and syncope were significantly more frequent in the intensive-treatment group. When trial and post-trial follow-up data were combined (3.88 years in total), similar patterns were found for treatment benefit and adverse events; however, rates of heart failure no longer differed between the groups. CONCLUSIONS: Among patients who were at increased cardiovascular risk, targeting a systolic blood pressure of less than 120 mm Hg resulted in lower rates of major adverse cardiovascular events and lower all-cause mortality than targeting a systolic blood pressure of less than 140 mm Hg, both during receipt of the randomly assigned therapy and after the trial. Rates of some adverse events were higher in the intensive-treatment group. (Funded by the National Institutes of Health; SPRINT ClinicalTrials.gov number, NCT01206062.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“From the first landmark 1967 Veterans Administration Cooperative Study2 to the 2021 SPRINT trial3, all outcome trials in hypertension have used the average of snapshot BP levels to demonstrate the efficacy of antihypertensive drug therapy in reducing cardiovascular events.”
From Blood pressure and its variability: classic and novel measurement techniques (2022) · cites this paper as [3]
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Self-citationCox’s regression model for counting processes: A large sample study
Andersen, P. K., & Gill, R. D. (1982) · The Annals of Statistics · doi:10.1214/aos/1176345976 · Cited by 4,419
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Self-citationThe J-Curve Phenomenon in Hypertension
Kang, Y.-Y., & Wang, J.-G. (2016) · Pulse · doi:10.1159/000446922 · Cited by 1,530
A stagewise rejective multiple test procedure based on a modified Bonferroni test
HOMMEL, G. (1988) · Biometrika · doi:10.1093/biomet/75.2.383 · Cited by 1,367
Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease
Appel, L. J., Wright, J. T., Greene, T., Agodoa, L. Y., Astor, B. C., Bakris, G. L., Cleveland, W. H., Charleston, J., Contreras, G., Faulkner, M. L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0910975 · Cited by 719
Ambrosius, W. T., Sink, K. M., Foy, C. G., Berlowitz, D. R., Cheung, A. K., Cushman, W. C., Fine, L. J., Goff, D. C., Johnson, K. C., Killeen, A. A., et al. (2014) · Clinical Trials · doi:10.1177/1740774514537404 · Cited by 544
Holtkamp, F. A., de Zeeuw, D., Thomas, M. C., Cooper, M. E., de Graeff, P. A., Hillege, H. J. L., Parving, H.-H., Brenner, B. M., Shahinfar, S., & Lambers Heerspink, H. J. (2011) · Kidney International · doi:10.1038/ki.2011.79 · Cited by 364
Cited by
Items 301–400 of 462
No Standard Risk Factors Is the Marker for Clinical Outcomes in Patients With Myocardial Infarction
Sakakura, K. (2024) · JACC Asia · doi:10.1016/j.jacasi.2024.04.006 · Cited by 2
Resistant arterial hypertension: is it really so or have we missed something?
Ионин, В. А. (2022) · Eurasian heart journal · doi:10.38109/2225-1685-2022-2-80-85 · Cited by 1
Santo, K., Sampaio, G., & Berwanger, O. B. (2023) · Revista Brasileira de Hipertensão · doi:10.47870/1519-7522/2023300122-7 · Cited by 32
Strandberg, T. E., Petrović, M., & Bénétos, A. (2023) · Practical issues in geriatrics · doi:10.1007/978-3-031-28061-0_18 · Cited by 1
Isolated Systolic Hypertension
Li, Y., & Staessen, J. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88369-6.00018-9 · Cited by 1
Fadem, S. Z. (2023) · Springer eBooks · doi:10.1007/978-3-031-39155-2_2 · Cited by 1
Implementation Research and Results of Hypertension Control Strategy and Model in Rural Areas
Sun, G., Wu, J., Zhang, P., Yu, Y., & Sun, Y. (2023) · Cardiology Discovery · doi:10.1097/cd9.0000000000000102 · Cited by 3
Pontes, U. O., Monteiro, G. T. R., Amaral, C. D. A., de Vasconcellos, M. T. L., & Amaral, T. L. M. (2024) · Arquivos de Ciências da Saúde da UNIPAR · doi:10.25110/arqsaude.v28i1.2024-10781 · Cited by 1
Pharmacotherapies for essential hypertension: an in-depth review
Raja, B. B. J. (2026) · doi:10.61577/ijcri.2024.100001 · Cited by 1
Shakthivel, C. D. (2024) · Advances in medical technologies and clinical practice book series · doi:10.4018/979-8-3693-2703-6.ch005 · Cited by 2
Kazibwe, R., Ahmad, M. I., Singh, S., Chen, L. Y., & Soliman, E. Z. (2024) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.70018 · Cited by 1
McEvoy, J. W., McCarthy, C. P., Brouwers, S., & Others, A. (2025) · HYPERTENSION · doi:10.22141/2224-1485.17.4.2024.372 · Cited by 2
Hypertension in People with Diabetic and Chronic Kidney Disease, Obesity, and Renin Secreting Tumors
Khan, S. H., & Weir, M. R. (2025) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-81292-7_3 · Cited by 2
Leow, A. S., Sule, A. A., Tay, J. C., Teong, H. H., Moy, W. L., Handa, P. K., Wu, Y. T., Chadachan, V. M., Oh, V. M. S., Sia, C., et al. (2025) · Singapore Medical Journal · doi:10.4103/singaporemedj.smj-2025-094 · Cited by 1
Li, Z., Tao, Q., Wu, Y., Hua, S., Li, Q., Wang, Z., Chen, Y., Li, Y., Qiu, Z., & Jin, W. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2583558 · Cited by 1
Pros and cons of lower blood pressure targets in chronic kidney disease
Hernandez, M. R. F., & Chang, T. I. (2025) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000001153 · Cited by 1
Sun, X., Lei, M., Wang, X. F., Wang, J., Li, Y., Li, C., Zhigang, Z., Zhang, C., Ma, W., & Xue, Z. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1703466 · Cited by 1
Abudukeremu, A., Luo, Q., Wang, M., Zhu, Q., Cai, X., Abuduheilili, Z., Tulake, S., Dang, Y., & Li, N. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.01.005 · Cited by 1
CREST-2: Early reflections on the primary results
Meschia, J. F., Lal, B. K., & Brott, T. (2026) · Seminars in Vascular Surgery · doi:10.1053/j.semvascsurg.2026.02.002 · Cited by 2
Lyu, Y., Zhang, J., Liu, Y., Liu, Y., Bian, W., Chen, K., Jiang, Z., Chen, T., & Li, C. (2026) · Circulation Population Health and Outcomes · doi:10.1161/circoutcomes.125.012643 · Cited by 2
Management of Hypertension in Adults
Johnson, A. E., Jackson, C. D., & Alexander, J. T. (2026) · JAMA · doi:10.1001/jama.2026.1132 · Cited by 1
McCormick, J. P., Bacquer, D. D., Jennings, C. S., Kotseva, K., Backer, G. D., Erlund, I., Ganly, S., Vihervaara, T., Lip, G. Y. H., Ray, K. K., et al. (2026) · Heart · doi:10.1136/heartjnl-2025-327413 · Cited by 1
Taler, S. J. (2026) · Annals of Internal Medicine · doi:10.7326/annals-26-01311 · Cited by 1
PREVENT Equations: Implications for Stroke Prevention
Ahmed, T., Mathew, R. O., Elkind, M. S. V., & Kulshreshtha, A. (2026) · Stroke · doi:10.1161/strokeaha.126.053362 · Cited by 1
Romero-Vera, L., la Fuente, J. L.-D., Guede-Rojas, F., Carvajal-Parodi, C., Araya-Sierralta, S., Pérez-Contreras, J., Ulloa-Díaz, D., & Perea, Á. R. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15145531 · Cited by 1
Santo, K., Martins, E. B., Silva, G. S., Guimaraes, P. O., Tavares, C. A. M., de Andrade, J. B. C., Monfardini, F., Nieri, J., Assis, S. R. L., Felício, J. S., et al. (2026) · American Heart Journal · doi:10.1016/j.ahj.2026.107545 · Cited by 1
Wang, M., Qian, F., Chu, X., Li, A. L., & Li, H. (2026) · QJM · doi:10.1093/qjmed/hcag200 · Cited by 1
Another STEP towards tighter control of blood pressure in the elderly
Volpe, M., & Patrono, C. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab728 · Cited by 1
Age-independent benefits of blood pressure lowering: are they applicable to all patients?
Volpe, M., & Patrono, C. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab825 · Cited by 2
Blood Pressure Management in the Patient with Chronic Kidney Disease
Muntner, P., Cushman, W. C., & Lerma, E. V. (2022) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.13040921 · Cited by 1
Improving outcomes for older hypertensive patients: is more intensive treatment better?
Deng, Y., Liu, Y., Li, Y., Bai, J., & Cai, J. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2058491 · Cited by 1
Who Is at Risk for Heart Failure?
Yancy, C. W., & Khan, S. S. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2022.0689 · Cited by 1
The cutoff BP values for hypertension should not be lowered in China
Guo, R., & Guo, Y.-F. (2022) · Hypertension Research · doi:10.1038/s41440-022-00969-2 · Cited by 1
Kim, D. H., Tatsuoka, C. M., Chen, Z., Wright, J. T., Odden, M. C., Beddhu, S., Bellows, B. K., Bress, A. P., Carson, T. Y., Cushman, W. C., et al. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-022-07753-5 · Cited by 1
Orthostatic hypotension in elderly: Do you measure orthostatic and clinostatic blood pressure?
Cacciatore, S., Spadafora, L., & Landi, F. (2022) · Heart Vessels and Transplantation · doi:10.24969/hvt.2022.349 · Cited by 1
Hypotension in Older Treated Hypertensive Patients. Epidemiological Burden and Detection Efficiency
Banegas, J. R. (2022) · ANALES RANM · doi:10.32440/ar.2022.139.02.rev02 · Cited by 2
Won, K., Choi, S., Chun, E. J., Park, S. H., Sung, J., Jung, H. O., & Chang, H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12113770 · Cited by 1
Kim, G., & Kim, M. (2023) · Journal of Hypertension · doi:10.1097/01.hjh.0000939092.84832.4e · Cited by 1
Gottlieb, E. R., & Gottlieb, S. S. (2023) · Cureus · doi:10.7759/cureus.46237 · Cited by 1
Landgraf, R., Aberle, J., Birkenfeld, A. L., Gallwitz, B., Kellerer, M., Klein, H. H., Müller‐Wieland, D., Nauck, M. A., Wiesner, T., & Siegel, E. G. (2024) · Die Diabetologie · doi:10.1007/s11428-023-01144-y · Cited by 1
Blood Pressure Management and Falls in Nursing Home Residents—A Matter of Balance
Canales, M. T., & Shorr, R. I. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.0506 · Cited by 1
Mohammedi, K., Pigeyre, M., Bosch, J., Yusuf, S., & Gerstein, H. C. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02383-z · Cited by 1
Awadhiya, O., Tiwari, A. K., Solanki, P., Lahiri, A., Shrivastava, N., Joshi, A., Pakhare, A. P., & Joshi, R. P. (2021) · medRxiv · doi:10.1101/2021.06.11.21258759 · Cited by 1
Hypertension research from Japan: advancing the field of renal denervation
Weber, M. A. (2021) · Hypertension Research · doi:10.1038/s41440-021-00814-y · Cited by 1
Optimizing Blood Pressure Components for a Healthy Brain
Fernández‐Jiménez, R., & Real, C. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.01.046 · Cited by 1
Ogimoto, A. (2024) · Hypertension Research · doi:10.1038/s41440-024-02034-6 · Cited by 1
Ning, G. (2025) · Journal of Diabetes · doi:10.1111/1753-0407.70053 · Cited by 1
Curneen, J. M. G., & McEvoy, J. W. (2025) · Heart · doi:10.1136/heartjnl-2025-326336 · Cited by 1
Single-pill combinations in the management of hypertension
An, D., Zhang, D., & Staessen, J. A. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag274 · Cited by 1
Windler, E. E. T., Zyriax, B., & Augustin, M. (2021) · Gynäkologische Endokrinologie · doi:10.1007/s10304-021-00418-2
Yu, Y., & Staessen, J. A. (2021) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2021.200122
Hemmstoffe des Renin-Angiotensin-Systems
Weber, F., & Anlauf, M. (2021) · Springer eBooks · doi:10.1007/978-3-662-63825-5_7
Lanthier, L., Lauzon, D., Plourde, M.-É., & Cauchon, M. (2022) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2021.12.002
Vorteile der scharfen Blutdruckeinstellung bestätigt
(2021) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1531-1046
Windler, E. E. T., Zyriax, B., & Augustin, M. (2022) · Journal für Gynäkologische Endokrinologie/Schweiz · doi:10.1007/s41975-022-00231-5
Hypertension in Older Adolescents and Young Adults
Rivara, M. B. (2022) · Springer eBooks · doi:10.1007/978-3-319-31420-4_52-2
Update in Outpatient General Internal Medicine: Practice-Changing Evidence Published in 2021
Wingo, M. T., Huber, J. M., Bornstein, S. L., Sundsted, K. K., Mauck, K. F., Szostek, J. H., Post, J. A., & Wieland, M. L. (2022) · The American Journal of Medicine · doi:10.1016/j.amjmed.2022.02.043 · Cited by 1
Conservative versus aggressive blood pressure reduction: Do we have a winner?
Lović, D. B., & Doumas, M. N. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.05.027
Goraya, N., & Moran, J. D. (2022) · Nephrology Self-Assessment Program · doi:10.1681/nsap.00032022
Novel insights into determinants and prevention of atrial fibrillation progression
Nguyen, B. (2022) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.238296875
Epidemiology and Outcomes of Hypertension
Taler, S. J. (2022) · Nephrology Self-Assessment Program · doi:10.1681/nsap.00052022
Management of hypertension in renal disease
Jagadesh, G. S., & Thuraisingham, R. C. (2023) · Medicine · doi:10.1016/j.mpmed.2022.11.006
Brewer, P. L. (2022) · Digital Commons - URI (University of Rhode Island) · doi:10.23860/diss-brewer-pamela-2022
DeMarzo, A. P. (2023) · Current Hypertension Reports · doi:10.1007/s11906-023-01239-3 · Cited by 1
Ryu, S. I., Kim, Y.-D., Kim, T., Ban, S. P., Bang, J. S., Kwon, O.-K., Oh, C. W., & Lee, S. U. (2023) · Research Square · doi:10.21203/rs.3.rs-2611843/v1
(2022) · The Journal of V N Karazin Kharkiv National University series Medicine · doi:10.26565/2313-6693-2022-44
Systolic Hypertension in the Elderly (SHEP)-1991
Eng, B., & Shah, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-25620-2_22
Yang, E., & Tang, O. (2023) · JACC Advances · doi:10.1016/j.jacadv.2023.100405
Research Progress on Clinical Treatment of Hypertension in the Elderly
侯, 俊. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1371573
Mahfoud, F., & Wijns, W. C. (2023) · Journal of the Society for Cardiovascular Angiography & Interventions · doi:10.1016/j.jscai.2023.101130
Assessing Risk and Preventing Nonmechanical Falls
Fadem, S. Z. (2023) · Springer eBooks · doi:10.1007/978-3-031-39155-2_5
The Effect of Blood Pressure on the Prognosis of Cardiovascular Disease
斯米力, ·. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13112450
Chen, C., Ren, X., Zhao, Y. W., Ouyang, M., MBiostat, Q. L., Wang, X., Li, Y., You, S., Wang, Y., Robinson, T. G., et al. (2024) · Cerebrovascular Diseases · doi:10.1159/000536275
Eschenhagen, T., & Weil, J. (2023) · Springer eBooks · doi:10.1007/978-3-662-68371-2_6
Treating Hypertension Complicated with Heart Failure: Going Beyond the Numbers
Bădilă, E., & Dorobanţu, M. (2023) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-39315-0_21
Disorders manifesting with systemic hypertension
Olczak, K., Ahmed, F., & Munroe, P. B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-822951-4.00001-1
Становська, Л. В., & Krynytska, І. (2024) · Bukovinian Medical Herald · doi:10.24061/2413-0737.28.2.110.2024.8
Gao, J. (2024) · Science and Technology of Engineering Chemistry and Environmental Protection · doi:10.61173/fjx4w228 · Cited by 1
Arias, A. A., Ferreira, A. V., Imm, M. R., & Kottapally, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-62220-5_11
Ma, H., Wang, M., Chu, Q., Mandizadza, O. O., Wu, L., Cong, R., Shi, Y., Mao, W., & Ji, C. (2024) · European journal of medical research · doi:10.1186/s40001-024-02164-0
Manual de farmacología aplicada en patología cardiovascular prevalente
Ferrari, E. H. (2024) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/175309 · Cited by 11
Shen, N. M., Wanigatunga, A. A., Michos, E. D., Ambrosius, W. T., & Lesko, C. R. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae474
Análise da relação entre a Hipertensão Arterial e a Doença Arterial Coronariana
Andrade, M. M. D. M. S., de Oliveira, V. A., Nobre, A. T. D. A., Alves, M. E. B. S., Santos, L. V. M., Quintela, W. L., Sandes, M. E. S., Santos, A. G., & Burgos, Ú. M. M. C. (2025) · Revista JRG de Estudos Acadêmicos · doi:10.55892/jrg.v8i18.1798
Weekly Journal Scan: the (BP)ROAD to optimal blood pressure control in type-2 diabetes
Pedicino, D., & Volpe, M. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehae894
Nonatherosclerotic Cardiovascular Disease in Chronic Kidney Disease
Pradhan, N., & Dobre, M. A. (2025) · Cardiology Clinics · doi:10.1016/j.ccl.2024.12.008 · Cited by 2
Sung, D.-E., Kang, J., Lee, E. M., & Sung, K.-C. (2025) · American Journal of Hypertension · doi:10.1093/ajh/hpaf012
Kattah, A. G. (2025) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2025.03.009
Kraft, L., & Latus, J. (2025) · Elsevier eBooks · doi:10.1016/b978-3-437-21183-6.00003-9
Gallwitz, B., Aberle, J., Birkenfeld, A. L., Fritsche, A., Kellerer, M., Klein, H. H., Landgraf, R., Müller‐Wieland, D., Müssig, K., Nauck, M. A., et al. (2025) · Die Diabetologie · doi:10.1007/s11428-025-01324-y
Evaluation and Treatment of Essential and Secondary Hypertension
Lyas, C., & Maxson, R. (2025) · Nephrology Self-Assessment Program · doi:10.58483/nsap.00052025
Brown, R. S. (2025) · Journal of Hypertension · doi:10.1097/hjh.0000000000004048
Goupil, R., Tsuyuki, R. T., Santesso, N. A., Terenzi, K. A., Habert, J., Cheng, G., Gysel, S. C., Bruneau, J., Leung, A. A. C., Campbell, N. R. C., et al. (2025) · Canadian Medical Association Journal · doi:10.1503/cmaj.241770-f · Cited by 1
Blutdruckziel unter 120 mm Hg? Die Messmethode ist ausschlaggebend
Popert, U. (2025) · Zeitschrift für Allgemeinmedizin · doi:10.1007/s44266-025-00406-w
Narcisse, D. I., Whittle, J., Rhodes, G. M., Stebbins, A., Wruck, L. M., Mulder, H. S., Kripalani, S. B., Muñoz, D., Effron, M. B., Gupta, K., et al. (2025) · Contemporary Clinical Trials · doi:10.1016/j.cct.2025.108030
Reddy, Y. N. V., & Bergeron, N. P. (2025) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2025.06.010
Obesidad y eventos cardiovasculares adversos mayores
Menéses, N. G. D., Iñiga, M. E. P., Zambrano, V. L. S., Cepeda, S. P. D., & Acosta, J. A. H. (2025) · Mediciencias UTA (Impresa)/Mediciencias UTA (En línea) · doi:10.31243/mdc.uta.v9i3.2929.2025
Watanabe, Y., Sakakura, K., Jinnouchi, H., Watanabe, Y., Taniguchi, Y., Tsukui, T., Hatori, M., Yamamoto, K., Seguchi, M., Kasahara, T., et al. (2025) · Internal Medicine · doi:10.2169/internalmedicine.5860-25
Goupil, R., Tsuyuki, R. T., Santesso, N. A., Terenzi, K. A., Habert, J., Cheng, G., Gysel, S. C., Bruneau, J., Leung, A. A. C., Campbell, N. R. C., et al. (2025) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/17151635251352537
Metadata
- Authors
- The SPRINT Research Group
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- The SPRINT Research Group
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-05-20
- Volume
- 384
- Issue
- 20
- Pages
- 1921-1930
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC9907774
- OpenAlex
- W3161638097
- Cited by
- 454
- References
- 20
- Citations by year
- 2026: 74 · 2025: 92 · 2024: 74 · 2023: 83 · 2022: 105 · 2021: 26
- FWCI
- 48.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health, National Heart, Lung, and Blood Institute
- National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
- NIH, National Institute on Aging
- NIH, National Institute of Neurological Disorders and Stroke
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- intensive blood pressure control, systolic blood pressure target, antihypertensive therapy, major adverse cardiovascular events, all-cause mortality, cardiovascular risk, adverse events, acute kidney injury, heart failure, post-trial follow-up, SPRINT trial, acute coronary syndrome, stroke, myocardial infarction, syncope, electrolyte imbalance, hypotension
- MeSH terms
- Aged, Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Female, Follow-Up Studies, Humans, Hypertension, Male, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.